Mary Smith

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial

Iman Satti, Joel N. Meyer, Stephanie A. Harris et al. · The Lancet Infectious Diseases · 2014 · 175 citations · Full text

Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study

Chukiat Sirivichayakul, Elizabeth A Barranco-Santana, Inés Esquilin-Rivera et al. · The Journal of Infectious Diseases · 2015 · 81 citations · Full text

Human Coronavirus 229E: Receptor Binding Domain and Neutralization by Soluble Receptor at 37°C

Jamie J. Breslin, Irene Mørk, Mary Smith et al. · Journal of Virology · 2003 · 76 citations · Full text

Receptor Binding Domain, Virus Structure, Molecular Virology +15

Aromatic Amino Acids in the Juxtamembrane Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Are Important for Receptor-Dependent Virus Entry and Cell-Cell Fusion

Megan W. Howard, Emily A. Travanty, Scott A. Jeffers et al. · Journal of Virology · 2008 · 65 citations · Full text

Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study

Richard Rupp, Gary J. Luckasen, Judith L. Kirstein et al. · Vaccine · 2015 · 64 citations · Full text